{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:15:26Z","timestamp":1792815326414,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.radonc.2018.09.019","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T19:47:11Z","timestamp":1539460031000},"page":"166-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)"],"prefix":"10.1016","volume":"131","author":[{"given":"Judi","family":"van Diessen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Jakob","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e8ne","family":"Damen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Sikorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Reymen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"van Elmpt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte","family":"Fredberg Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9133-7877","authenticated-orcid":false,"given":"Edith","family":"Dieleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Bjorkestrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-9781","authenticated-orcid":false,"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Belderbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.09.019_b0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0010","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Auperin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2018.09.019_b0020","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1200\/JCO.2012.41.6677","article-title":"Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis","volume":"30","author":"Mauguen","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2006.09.005","article-title":"Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972\u201322973)","volume":"43","author":"Belderbos","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2018.09.019_b0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2015.64.8824","article-title":"PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer","volume":"34","author":"Senan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.radonc.2016.02.011","article-title":"Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab","volume":"118","author":"Walraven","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0040","unstructured":"Bradley, J.D.E.A. Long-term results of RTOG 0617. 2017; Available from: www.astro.org\/uploadedFiles\/_MAIN_SITE\/News_and_Publications\/News_and_Media_Center\/Press_Kits\/2017\/Annual_Meeting\/Content_Pieces\/ASTRO17%20Briefing%20Slides_Bradley.pdf"},{"key":"10.1016\/j.radonc.2018.09.019_b0045","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ijrobp.2004.12.019","article-title":"Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study","volume":"62","author":"De Ruysscher","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.019_b0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/0284186X.2013.868035","article-title":"Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer","volume":"53","author":"Schytte","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.radonc.2016.02.008","article-title":"Differential analysis of local and regional failure in locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy","volume":"118","author":"van Diessen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/0284186X.2017.1293288","article-title":"Is there a different dose-effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study","volume":"56","author":"Van den Bosch","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0065","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ijrobp.2007.11.070","article-title":"Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study","volume":"71","author":"van Baardwijk","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.019_b0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/0284186X.2013.790560","article-title":"Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose","volume":"53","author":"Nielsen","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0075","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2005.02.010","article-title":"High-dose radiation improved local tumor control and overall survival in patients with inoperable\/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study","volume":"63","author":"Kong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.019_b0080","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.radonc.2013.12.005","article-title":"Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR)","volume":"110","author":"Reymen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0085","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2008.10.054","article-title":"Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing","volume":"73","author":"Feng","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.019_b0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.radonc.2009.01.003","article-title":"Is pre-therapeutical FDG-PET\/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?","volume":"91","author":"Abramyuk","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fonc.2012.00071","article-title":"Current concepts in F18 FDG PET\/CT-based radiation therapy planning for lung cancer","volume":"2","author":"Lee","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0100","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ijrobp.2007.11.049","article-title":"Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study","volume":"71","author":"Aerts","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.019_b0105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.radonc.2009.03.006","article-title":"Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan","volume":"91","author":"Aerts","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0110","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1200\/JCO.2012.47.5947","article-title":"Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668\/RTOG 0235 trial","volume":"31","author":"Machtay","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0115","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MCP.0000000000000182","article-title":"Update on F-18-fluoro-deoxy-glucose-PET\/computed tomography in nonsmall cell lung cancer","volume":"21","author":"Usmanij","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.radonc.2018.09.019_b0120","first-page":"41","article-title":"Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology","volume":"139","author":"Bentzen","year":"2008","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.radonc.2018.09.019_b0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.radonc.2009.02.020","article-title":"Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study","volume":"91","author":"Petit","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/JTO.0b013e31827dc74d","article-title":"Effect of tumor size on prognosis in patients treated with radical radiotherapy or chemoradiotherapy for non-small cell lung cancer. An analysis of the staging project database of the International Association for the Study of Lung Cancer","volume":"8","author":"Ball","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0135","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s00259-008-0874-2","article-title":"The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials","volume":"35","author":"Boellaard","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2018.09.019_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2012.03.005","article-title":"The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer","volume":"104","author":"van Elmpt","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.radonc.2013.08.017","article-title":"Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy","volume":"108","author":"Chen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0150","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1200\/JCO.2013.51.5353","article-title":"Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer","volume":"31","author":"Cannon","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12885-016-2314-1","article-title":"Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy\/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial","volume":"16","author":"Ren","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2018.09.019_b0160","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijrobp.2017.10.042","volume":"100","author":"Jeter","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.019_b0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/JTO.0b013e3181915028","article-title":"Late complications of high-dose (>\/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer","volume":"4","author":"Lee","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-8140(98)00103-0","article-title":"Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?","volume":"49","author":"Langendijk","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0175","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamaoncol.2017.0982","article-title":"Effect of midtreatment PET\/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non-small-cell lung cancer: a phase 2 clinical trial","volume":"3","author":"Kong","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2018.09.019_b0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijrobp.2018.01.046","article-title":"Phase 1 study of accelerated hypofractionated radiation therapy with concurrent chemotherapy for stage III non-small cell lung cancer: CALGB 31102 (Alliance)","volume":"101","author":"Urbanic","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.019_b0185","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijrobp.2014.02.011","article-title":"Pulmonary artery invasion, high-dose radiation, and overall survival in patients with non-small cell lung cancer","volume":"89","author":"Han","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T13:38:40Z","timestamp":1565271520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018335023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":37,"alternative-id":["S0167814018335023"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.09.019","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}